The Reappraisal of the Reappraisal-CRAC Channels Are Activated by L-Type Ca Channel Blockers, Reply to Bird et al.
作者信息
Trebak Mohamed, Machaca Khaled, Hogan Patrick G
机构信息
Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.
出版信息
Function (Oxf). 2024 Feb 2;5(2):zqae007. doi: 10.1093/function/zqae007. eCollection 2024.
Abstract
摘要
相似文献
1
The Reappraisal of the Reappraisal-CRAC Channels Are Activated by L-Type Ca Channel Blockers, Reply to Bird et al.《重新评估的再评估——L型钙通道阻滞剂激活CRAC通道，回应伯德等人》
Function (Oxf). 2024 Feb 2;5(2):zqae007. doi: 10.1093/function/zqae007. eCollection 2024.
2
Store-operated CRAC channel inhibitors: opportunities and challenges.储存性钙释放激活钙通道抑制剂：机遇与挑战。
Future Med Chem. 2016 May;8(7):817-32. doi: 10.4155/fmc-2016-0024. Epub 2016 May 5.
3
Molecular pharmacology of store-operated CRAC channels.钙激活的氯离子通道的分子药理学。
Channels (Austin). 2013 Sep-Oct;7(5):402-14. doi: 10.4161/chan.25292. Epub 2013 Aug 26.
4
Molecular action mechanisms of two novel and selective calcium release-activated calcium channel antagonists.两种新型选择性钙释放激活钙通道拮抗剂的分子作用机制。
Int J Biol Macromol. 2023 Dec 31;253(Pt 3):126937. doi: 10.1016/j.ijbiomac.2023.126937. Epub 2023 Sep 16.
5
Microglial Calcium Release-Activated Calcium Channel Inhibition Improves Outcome from Experimental Traumatic Brain Injury and Microglia-Induced Neuronal Death.小胶质细胞钙释放激活钙通道抑制改善实验性颅脑损伤和小胶质细胞诱导的神经元死亡的预后。
J Neurotrauma. 2019 Apr 1;36(7):996-1007. doi: 10.1089/neu.2018.5856. Epub 2018 Dec 4.
6
Discovery and structural optimization of 1-phenyl-3-(1-phenylethyl)urea derivatives as novel inhibitors of CRAC channel.1-苯基-3-(1-苯乙基)脲衍生物作为新型钙释放激活钙通道（CRAC通道）抑制剂的发现与结构优化
Acta Pharmacol Sin. 2015 Sep;36(9):1137-44. doi: 10.1038/aps.2015.52. Epub 2015 Aug 10.
7
The action of selective CRAC channel blockers is affected by the Orai pore geometry.选择性 CRAC 通道阻滞剂的作用受 Orai 孔几何形状的影响。
Cell Calcium. 2013 Feb;53(2):139-51. doi: 10.1016/j.ceca.2012.11.005. Epub 2012 Dec 5.
8
Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.兰尼碱受体与钙释放激活钙（CRAC）通道机械装置之间的双向偶联维持了人 T 淋巴细胞中的钙库操纵性钙内流。
J Biol Chem. 2012 Oct 26;287(44):37233-44. doi: 10.1074/jbc.M112.398974. Epub 2012 Sep 4.
9
Discovery of selective Orai channel blockers bearing an indazole or a pyrazole scaffold.发现具有吲唑或吡唑骨架的选择性 Orai 通道阻滞剂。
Eur J Med Chem. 2024 Nov 15;278:116805. doi: 10.1016/j.ejmech.2024.116805. Epub 2024 Aug 28.
10
Properties of Ca(2+) release-activated Ca(2+) channel block by 5-nitro-2-(3-phenylpropylamino)-benzoic acid in Jurkat cells.5-硝基-2-(3-苯丙基氨基)苯甲酸对Jurkat细胞中钙释放激活钙通道的阻断特性
Eur J Pharmacol. 2000 Apr 14;394(2-3):171-9. doi: 10.1016/s0014-2999(00)00144-8.
引用本文的文献
1
L-type calcium channel blockers at therapeutic concentrations are not linked to CRAC channels and heart failure.治疗浓度的L型钙通道阻滞剂与钙释放激活钙通道及心力衰竭无关。
Clin Exp Hypertens. 2025 Dec;47(1):2515924. doi: 10.1080/10641963.2025.2515924. Epub 2025 Jul 12.
本文引用的文献
1
Overcoming Confounding to Characterize the Effects of Calcium Channel Blockers.克服混杂因素以明确钙通道阻滞剂的作用
Function (Oxf). 2023 Oct 12;4(6):zqad054. doi: 10.1093/function/zqad054. eCollection 2023.
2
A Reappraisal of the Effects of L-type Ca Channel Blockers on Store-Operated Ca Entry and Heart Failure.L 型钙通道阻滞剂对钙库操纵性钙内流和心力衰竭作用的再评价。
Function (Oxf). 2023 Oct 12;4(6):zqad047. doi: 10.1093/function/zqad047. eCollection 2023.
3
How Do We Clean Up the Scientific Record?我们如何清理科学记录？
Function (Oxf). 2023 Oct 12;4(6):zqad055. doi: 10.1093/function/zqad055. eCollection 2023.
4
L-type Ca channel blockers promote vascular remodeling through activation of STIM proteins.L型钙通道阻滞剂通过激活基质相互作用分子（STIM）蛋白促进血管重塑。
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17369-17380. doi: 10.1073/pnas.2007598117. Epub 2020 Jul 8.
5
Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ.钙库操纵型钙内流（SOCE）的诱导通过抑制 Hippo 通路转录共激活因子 YAP/TAZ 抑制胶质母细胞瘤的生长。
Oncogene. 2019 Jan;38(1):120-139. doi: 10.1038/s41388-018-0425-7. Epub 2018 Aug 6.
6
Orai1-mediated I (CRAC) is essential for neointima formation after vascular injury.Orai1 介导的钙库操纵性钙内流（CRAC）对于血管损伤后的新生内膜形成是必需的。
Circ Res. 2011 Aug 19;109(5):534-42. doi: 10.1161/CIRCRESAHA.111.246777. Epub 2011 Jul 7.
7
Plasma protein binding in drug discovery and development.药物发现与开发中的血浆蛋白结合
Comb Chem High Throughput Screen. 2010 Feb;13(2):170-87. doi: 10.2174/138620710790596745.
8
Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration.血管平滑肌细胞中通过ICRAC的STIM1和Orai1依赖性钙库操纵性钙内流的证据：在增殖和迁移中的作用
FASEB J. 2009 Aug;23(8):2425-37. doi: 10.1096/fj.09-131128. Epub 2009 Apr 13.
9
The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease.非兴奋性平滑肌：血管疾病中的钙信号传导与表型转换
Pflugers Arch. 2008 Aug;456(5):769-85. doi: 10.1007/s00424-008-0491-8. Epub 2008 Mar 26.
10
Clinical pharmacokinetics of vasodilators. Part I.血管扩张剂的临床药代动力学。第一部分。
Clin Pharmacokinet. 1998 Jun;34(6):457-82. doi: 10.2165/00003088-199834060-00003.
Zotero 插件